Creatd, Inc. implemented a 1:20 reverse stock split effective February 24, 2026, as part of its strategy to uplist from the OTCQB market. The company's latest updates are available at https://tinyurl.com/crtdnewsroom. Blackboxstocks Inc. announced that Nasdaq approved the listing of REalloys in connection with their merger, which closed after market hours on February 24, 2026. The combined company began trading on Nasdaq under the ticker "ALOY" on February 25, 2026, with further information at https://tinyurl.com/blbxnewsroom.
Shorepower Technologies entered a merger agreement with Aeternum Health LLC, signaling a strategic transition from transportation electrification infrastructure to a longevity-focused healthcare platform. Tianrong Internet Products and Services Inc. provided an update on its DEPIN token launch on the Solana blockchain via Raydium and outlined Phase II expansion for its Depinfer project, with details accessible at https://tinyurl.com/tipsnewsroom.
Renewal Fuels, operating as American Fusion, appointed Fabrice David as an independent director and provided updates on its legal matters and intellectual property portfolio, including the filing of 20 Texatron™ patent applications. The company's newsroom at https://tinyurl.com/rnwfnewsroom contains ongoing developments. Auddia Inc. highlighted its LT350 distributed AI compute business as a core asset in a proposed merger, addressing GPU underutilization and grid-constrained datacenter deployment through innovative infrastructure solutions.
JP3E Holdings partnered with TBURN Chain Foundation to deploy the K2Global SMB500 Platform in Atlanta and Dallas, integrating 500 Korean small and mid-sized enterprises into US manufacturing clusters using blockchain technology. AmpliTech Group and Northeastern University demonstrated the first open-source massive MIMO O-RAN system with Category B fronthaul, marking a significant advancement in telecommunications infrastructure using interoperable components. Quoin Pharmaceuticals launched its 'NETHERTON NOW' campaign to raise awareness of Netherton Syndrome, highlighting ongoing efforts in rare disease advocacy.
